SAI Life Sciences Ltd Executive and Leadership Team

Ravi Badgi, the Chief Executive Officer at SAI Life Sciences Ltd, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of drug discovery and manufacturing services, the Chief Executive Officer ensures alignment between technical capabilities and client requirements. This leadership role involves managing complex cross-functional teams to optimize the delivery of synthetic and medicinal chemistry solutions. By fostering a culture of scientific excellence, Ravi Badgi drives the company toward achieving ambitious growth targets within the global pharmaceutical market. The Chief Executive Officer maintains rigorous standards for quality and compliance across all research and development initiatives. Through strategic oversight of internal processes, the Chief Executive Officer secures the operational efficiency necessary to support biotechnology partners. Ultimately, Badgi strengthens the market position of the firm by prioritizing innovation and sustainable development in every facet of the business.

Krishna Kanumuri, the Chief Executive Officer & Managing Director at SAI Life Sciences Ltd, architects the high-level business model and governs the expansion of manufacturing capabilities. Overseeing the strategic direction of the firm, the Chief Executive Officer & Managing Director ensures that the organization meets the evolving needs of the global biotechnology sector. This leadership role involves managing relationships with key stakeholders and guiding the company through complex regulatory landscapes. By focusing on the scalability of NCE formulation and generic development, Krishna Kanumuri drives significant value for international clients. The Chief Executive Officer & Managing Director monitors the performance of diverse service lines to ensure consistent delivery of high-quality scientific outcomes. Through the implementation of robust management frameworks, the Chief Executive Officer & Managing Director sustains the competitive advantage of the company. Ultimately, Kanumuri leads the organization toward long-term financial stability and operational excellence.

Gautham Manoj, the Chief of Staff at SAI Life Sciences Ltd, coordinates internal operations and facilitates communication across the executive leadership team. Overseeing the execution of strategic initiatives, the Chief of Staff ensures that departmental goals align with the broader mission of the company. This leadership role involves managing special projects that enhance organizational productivity and streamline decision-making processes. By optimizing internal workflows, Gautham Manoj drives efficiency in the delivery of drug discovery and development services. The Chief of Staff acts as a primary liaison between the board and functional heads to maintain operational transparency. Through the rigorous monitoring of key performance indicators, the Chief of Staff supports the achievement of corporate milestones. Ultimately, Manoj improves the agility of the firm by removing bottlenecks and fostering collaboration across all research and manufacturing divisions to ensure seamless project delivery.

Anindya Manna, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem at SAI Life Sciences Ltd, directs the commercial strategy for medicinal chemistry and drug discovery services. Overseeing the technical sales pipeline, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem ensures that scientific expertise translates into tangible revenue growth for the organization. This leadership role involves bridging the gap between complex chemistry requirements and client-specific drug development needs. By leveraging deep technical knowledge, Anindya Manna drives the acquisition of new partnerships within the global pharmaceutical industry. The A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem collaborates with research teams to refine service offerings and improve market penetration. Through the strategic management of client portfolios, the A. R. Scientist. Chief Revenue Officer. Drug Discovery and Development. MedChem secures consistent project flow. Ultimately, Manna enhances the reputation of the firm as a premier provider of advanced chemical solutions.

Anil Chilagani, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) at SAI Life Sciences Ltd, manages the business development lifecycle and operational excellence for discovery services. Overseeing the expansion of the client base, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) ensures that the company maintains a strong presence in the competitive drug discovery market. This leadership role involves identifying new opportunities for growth and optimizing the delivery of biology and chemistry services. By implementing lean methodologies, Anil Chilagani drives operational efficiency and improves the overall profitability of discovery projects. The Chief Revenue Officer, Agm Disovery Oe Lead ( Business) coordinates with cross-functional teams to ensure that client expectations are met with precision and speed. Through the strategic alignment of business goals with scientific capabilities, the Chief Revenue Officer, Agm Disovery Oe Lead ( Business) fosters long-term client loyalty. Ultimately, Chilagani secures the financial health of the discovery division.

Khursheed Syed, the Chief of Staff - CMC at SAI Life Sciences Ltd, directs the operational coordination of Chemistry, Manufacturing, and Controls (CMC) activities. Overseeing the integration of pre-formulation and generic formulation development, the Chief of Staff - CMC ensures that all technical processes meet stringent quality standards. This leadership role involves managing the flow of information between manufacturing units and development teams to accelerate project timelines. By streamlining the transition from drug discovery to commercial manufacturing, Khursheed Syed drives the successful delivery of complex pharmaceutical products. The Chief of Staff - CMC monitors resource allocation and project milestones to ensure that the company meets its commitments to global biotechnology partners. Through the implementation of rigorous oversight mechanisms, the Chief of Staff - CMC maintains the integrity of the manufacturing pipeline. Ultimately, Syed supports the growth of the firm by ensuring that CMC operations remain efficient, scalable, and compliant with international regulations.